麒麟信安(688152.SH):部分募投項目擬新增實施主體並投資設立子公司
格隆匯2月14日丨麒麟信安(688152.SH)公佈,基於公司長期戰略規劃和實際經營發展需要,公司擬在重慶市設立全資子公司重慶麒麟信安科技有限公司(暫定名,以工商行政管理部門覈準的名稱爲準,簡稱“重慶麒麟信安”),並新增該全資子公司爲公司募集資金投資項目“區域營銷及技服體系建設項目”的實施主體。公司與該全資子公司之間將通過注資、內部往來等方式具體劃轉募投項目實施所需募集資金,募投項目其他內容均不發生變更。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.